Anti-Mouse PD-L1 Antibody
目录号 : GC66337
Anti-Mouse PD-L1 Antibody(10F.9G2)是抗小鼠PD-L1(CD274/B7-H1)的IgG2b抗体抑制剂,宿主是大鼠(Rat)。
Sample solution is provided at 25 µL, 10mM.
Anti-Mouse PD-L1 Antibody (10F.9G2) is an IgG2b antibody inhibitor against mouse PD-L1 (CD274/B7-H1), and the host is rat (Rat)[1]. Anti-Mouse PD-L1 Antibody can be used in animals to block PD-L1[2]. PD-L1 is one of the ligands of programmed death-1 (PD-1), the other is PD-L2. PD-1 is a member of the CD28 superfamily. Inhibition of the PD-1 pathway accelerates and enhances autoimmunity[3]. Inhibitors of PD-1 and its ligands, collectively known as immune checkpoint inhibitors, can enhance T cell responses[4]. PD-L1 is abundantly expressed in many mouse and human cancers and can be further upregulated under IFN-γ stimulation[5].
References:
[1] Stewart R, Morrow M, Hammond S A, et al. Identification and characterization of MEDI4736, an antagonistic anti–PD-L1 monoclonal antibody[J]. Cancer immunology research, 2015, 3(9): 1052-1062.
[2] Dai S, Jia R, Zhang X, et al. The PD-1/PD-Ls pathway and autoimmune diseases[J]. Cellular immunology, 2014, 290(1): 72-79.
[3] Dong Y, Sun Q, Zhang X. PD-1 and its ligands are important immune checkpoints in cancer[J]. Oncotarget, 2017, 8(2): 2171.
[4] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer[J]. American journal of cancer research, 2020, 10(3): 727.
[5] He R, Yang X, Liu C, et al. Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model[J]. Cellular & molecular immunology, 2018, 15(9): 815-826.
Anti-Mouse PD-L1 Antibody(10F.9G2)是抗小鼠PD-L1(CD274/B7-H1)的IgG2b抗体抑制剂,宿主是大鼠(Rat)[1]。Anti-Mouse PD-L1 Antibody可以在动物体内应用,阻断PD-L1[2]。PD-L1是程序性死亡-1(PD-1)的其中一个配体,另一个是PD-L2,PD-1是CD28超家族成员,PD-1通路的抑制会加速和加强自身免疫[3]。PD-1以及其配体的抑制剂,通称为免疫检查点抑制剂,能够增强T细胞反应[4]。许多小鼠和人类癌症中PD-L1的表达丰富,并且在IFN-γ刺激下可以进一步上调[5]。
Cas No. | SDF | Download SDF | |
分子式 | 分子量 | 49/23kDa | |
溶解度 | 储存条件 | Store at -80°C | |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 20.4082 mL | 102.0408 mL | 204.0816 mL |
5 mM | 4.0816 mL | 20.4082 mL | 40.8163 mL |
10 mM | 2.0408 mL | 10.2041 mL | 20.4082 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
-
Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet